Lack of pharmacokinetic and pharmacodynamic interaction between valsartan and warfarin

被引：0
|
作者：
Knight, H
Flesch, G
Prasad, P
Lloyd, P
Douglas, J
机构：
[1] Novartis Pharmaceut, Horsham, W Sussex, England
[2] Novartis Pharmaceut, Basel, Switzerland
[3] Novartis Pharmaceut, E Hanover, NJ USA
来源：
JOURNAL OF HYPERTENSION | 2000年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [1] NO PHARMACOKINETIC OR PHARMACODYNAMIC INTERACTION BETWEEN RIVASTATIN AND WARFARIN
    SCHALL, R
    MULLER, FO
    HUNDT, HKL
    RITTER, W
    DUURSEMA, L
    GROENEWOUD, G
    MIDDLE, MV
    JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (03): : 306 - 313
  • [2] Lack or pharmacokinetic interaction between valsartan and indomethacin
    Lloyd, P
    Prasad, P
    Mueller, P
    JOURNAL OF HYPERTENSION, 2000, 18 : S210 - S210
  • [3] LACK OF A PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION BETWEEN DIMEBON (LATREPIRDINE) AND WARFARIN IN HEALTHY SUBJECTS.
    Plowchalk, D. R.
    Qiu, R.
    Terra, S. G.
    Corrigan, B.
    Fang, J.
    Fullerton, T.
    Liu, J.
    Byon, W.
    Mordenti, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S57 - S57
  • [4] A PHARMACOKINETIC/PHARMACODYNAMIC INTERACTION STUDY BETWEEN CARISBAMATE AND WARFARIN
    Gonzalez, Martha D.
    Zannikos, Peter
    Ariyawansa, Jay
    Brashcar, H. Robert
    Romano, Gary
    Janssen, Tom
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1116 - 1116
  • [5] Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin
    Sreeneeranj Kasichayanula
    Ming Chang
    Xiaoni Liu
    Wen-Chyi Shyu
    Steven C. Griffen
    Frank P. LaCreta
    David W. Boulton
    Advances in Therapy, 2012, 29 : 163 - 177
  • [6] Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin
    Kasichayanula, Sreeneeranj
    Chang, Ming
    Liu, Xiaoni
    Shyu, Wen-Chyi
    Griffen, Steven C.
    LaCreta, Frank P.
    Boulton, David W.
    ADVANCES IN THERAPY, 2012, 29 (02) : 163 - 177
  • [7] LACK OF PHARMACODYNAMIC INTERACTION BETWEEN PENTOXIFYLLINE AND WARFARIN IN THE RAT
    LUKE, DR
    ODONNELL, MP
    KEANE, WF
    MATZKE, GR
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1986, 54 (01): : 65 - 72
  • [8] Lack of pharmacokinetic and pharmacodynamic interaction between rizatriptan and paroxetine
    Goldberg, MR
    Lowry, RC
    Musson, DG
    Birk, KL
    Fisher, A
    DePuy, ME
    Shadle, CR
    JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (02): : 192 - 199
  • [9] Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil
    Periclou, AP
    Ventura, D
    Sherman, T
    Rao, N
    Abramowitz, WT
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (09) : 1389 - 1394
  • [10] Pharmacokinetic and Pharmacodynamic Interaction Between Tolvaptan and Warfarin in Healthy Subjects
    Shoaf, Susan E.
    Mallikaarjun, Suresh
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2012, 1 (02): : 67 - 75
12345